信息来源: https://qsymia.com/patient/include/media/pdf/prescribing-information.pdf?v=0422 注:药品如有新包装,以新包装为准。以上说明书为高等医药院校的学生志愿者翻译(如有错漏,请帮忙指正),仅供医护人员内部讨论,不作任何用药依据,具体用药指引,...
美国食品药品监督管理局(FDA)于2022年6月27日批准了Vivus公司的Qsymia(芬特明和托吡酯缓释胶囊)的补充新药申请(sNDA),作为12岁及以上体重指数(BMI)在95%或更高的年龄和性别标准化的儿科患者慢性体重管理的低热量饮食和增加身体活动的辅助手段。 Qsymia是一种附表IV受控物质,此前也获批用于初始身体质量指数为30kg/m2...
Qsymia should be discontinued at the first sign of a rash, unless the rash is clearly not drug related. If signs or symptoms suggest SJS/TEN, use of this drug should not be resumed, and alternative therapy should be considered. Inform patients about the signs of serious skin reactions. The...
More on Drugs & Medications Drug Recalls: What Do They Mean? Choosing an OTC Pain Reliever: What to Consider Is Your Medication Making You Tired?Sign up for our free Cholesterol Management Newsletter Get the latest news and information about lowering cholesterol Subscribe By clicking Subscribe, ...
Qsymia (Phentermine and Topiramate) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.
head> QSYMIA.QSYMIA.The article presents information on the drug Qsymia from Vivus Inc.EBSCO_AspMPR - Pharmacist's Edition
A new oral Weight-loss drug——Qsymia XIAO Dian, ZHOU Xin-bo* Author information + 文章历史 + 摘要 Qsymia 是由美国Vivus 公司开发的新型复方减肥药,2012 年7 月17 日,美国FDA 批准其作为节食和锻炼疗法的辅助治疗药,适用对象为体质指数(BMI) 为30 及以上或27 及以上且患有与体重相关的疾病( ...
Qsymia - Get up-to-date information on Qsymia side effects, uses, dosage, overdose, pregnancy, alcohol and more. Learn more about Qsymia
FDA approves weight-management drug Qsymia. FDA News Release. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312468.htm (Accessed 10 Sept 2012) Rothman RB, Baumann MH. Appetite suppressants, cardiac valve disease and combination pharmacotherapy. Am J Ther 2009; 16 (4): 354–64 ...